13/05/2026
Yesterday, Helen, our Operations Manager, and Sarah Baker, our new CEO, had an inspiring and thought-provoking day at the LifeArc Translational Science Summit 2026 . It brought together leaders, researchers, advocates, patients, clinicians, charities and organisations from across the rare disease and health innovation community.
The summit explored a wide range of important topics including rare disease regulations, the evolving Rare Disease Action Plan, AI as a medical device, personalised medicines, and the opportunities and challenges within rare disease research and innovation.
We were particularly inspired by the opening reflections from Ian Gilham, Chair of Trustees, and Dr Sam Barrell CBE, CEO at LifeArc, who shared LifeArc’s vision around igniting innovation and turning discovery into impact. The conference closed with a powerful talk from Julian Vitarello, Mila's Miracle Foundation reminding everyone why collaboration and urgency matter so deeply in the rare disease community.
Alongside the learning, one of the most valuable aspects of the summit was the opportunity to connect with others across the sector, strengthening relationships and building new collaborations that can help improve outcomes for people living with rare conditions.
A huge thank you to LifeArc for hosting such an impactful event and for creating a space that encouraged openness, learning and collaboration across the rare disease ecosystem.